Caffeine for Hypoxic-Ischemic Encephalopathy
Clinical trial NCT03913221 · COMPLETED
Trial details
- NCT number
- NCT03913221
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-14
- Primary completion
- 2023-01-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.